FDA grants Eisai’s Leqembi full approval, opening door to wider use of Alzheimer’s drug
The broader approval is expected to push insurers, namely Medicare, to increase coverage of amyloid-targeting therapies.
Related Articles
Nurses have a deep distrust of AI – but transparency and training
The California Nurses Association recently organized a San Francisco protest aimed at Kaiser Permanente, saying its use of artificial intelligence in patient care is a…
How Intuitive plans to use da Vinci 5 data to drive innovation and improve surgical outcomes
Intuitive believes DV5 data can enhance surgeon training and predict surgical robotics outcomes, Chief Digital Officer Brian Miller says.
Task Force Issues Final Recommendation Statement on Screening for Breast Cancer
April 30, 2024 — The U.S. Preventive Services Task Force (Task Force) today published a final recommendation statement on screening for breast cancer. The notification…
Senseonics gets FDA clearance to pair CGM implant with insulin pumps
Analysts said the designation and planned one-year sensor could help Senseonics’ device appeal to more patients.
Why hospital executives think Walmart Health failed
Health system leaders discuss the failure of Walmart Health, citing challenging economics and the difficulty of providing primary care at scale.
PocketHealth Launches Basic | PocketHealth
PocketHealth Basic provides free access to view and share your medical imaging records, helping you become a more informed participant in your healthcare journey.
CMR leaders on the ‘massive advantage’ of Versius and growing robotic surgery penetration
CMR Surgical leaders say it’ll take the right surgical robot to expand global adoption — and that their Versius system is just the thing.
Transcarent raises $126M, bringing its valuation to $2.2B
The company will use the funds to accelerate its AI capabilities as well as strategic and commercial growth.
Is Regulating Healthcare Costs Counterproductive? SC Order Opens Pandora’s Box
The Indian private healthcare sector, the largest in the world, has so far was seen as being largely unregulated.